Use of Nintedanib for the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States
Annals of the American Thoracic Society | April 10, 2025 | Volume: 22 | Issue: 8 | Pages: 1265-1269
10.1513/annalsats.202410-1045rl
| PMID 40208257